Myocardial infarction (MI) is the leading cause of morbidity and mortality worldwide. Despite
extensive efforts to provide early diagnosis and adequate treatment regimens, detection of …

Importance Mortality is a common outcome in trials comparing percutaneous coronary
intervention (PCI) with coronary artery bypass grafting (CABG). Controversy exists regarding …

Background Cardiogenic shock secondary to acute myocardial infarction (AMI-CS) is
associated with substantial short-term mortality; however, there are limited data on long-term …

Background and objectives: Ischemic heart disease represents the leading cause of death,
emphasizing risk stratification and early therapeutic intervention. Heart rate variability (HRV) …

Our objective was to compare long-term outcomes in patients with non-ST-elevation
myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI) between two …

Background While immune checkpoint inhibitors (ICIs) are associated with elevated
cardiovascular risks, evidence of any association between ICIs and myocardial infarction …

Background The aim of this clinical research was to investigate the effects of Pressure-
controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size at 5 days after …

Background: The randomized DAPA trial (Defibrillator After Primary Angioplasty) aimed to
evaluate the survival benefit of prophylactic implantable cardioverter defibrillator (ICD) …

Background: Cardiogenic shock (CS) exhibits high (~ 50%) in-hospital mortality. The
recently published Extracorporeal life Support in Cardiogenic Shock (ECLS-SHOCK) trial …

The phospholipid bilayer membrane that surrounds each cell in the body represents the first
and last line of defense for preserving overall cell viability. In several forms of cardiac and …